Company / PP&E (Net)
Teladoc Health, Inc. PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$27.0M
FY2025
5-year range
$27.0M / $32.0M
FY2021-FY2025
Trend
-8.5%
vs FY2024
Sector context
#109 of 135
Health Care
What the data says
Teladoc Health, Inc.'s pp&e (net) of $27M is lower than 81% of companies in the Health Care sector (FY2025). PP&E (Net) has fluctuated over the past 10 years, ranging from $7M in FY2016 to $32M in FY2023.
Based on SEC 10-K filings.
$27M in FY2025 with a 5-year CAGR of -1.1%.
Declined from $32M to $27M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -3.1%
- 5-Year CAGR
- -1.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 135This company $27.0M Sector average $1.4B
▼
-98.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -1.1%, indicating a declining trend.
- In FY2025, pp&e (net) decreased 8.5% year-over-year.
- Ranks #109 out of 135 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -3.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $27.0M | -8.5% |
| FY2024 | $29.5M | -7.9% |
| FY2023 | $32.0M | +8.1% |
| FY2022 | $29.6M | +8.8% |
| FY2021 | $27.2M | -4.6% |
| FY2020 | $28.6M | +177.3% |
| FY2019 | $10.3M | +1.5% |
| FY2018 | $10.1M | +13.2% |
| FY2017 | $9.0M | +19.8% |
| FY2016 | $7.5M | +19.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026